Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00330486
Status:
COMPLETED
Last Update Posted:
2008-09-19
First Post:
2006-05-25
Brief Title:
Open Label Trial of Acamprosate in Bipolar Alcoholics
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Study Overview
Official Title:
The Use of Acamprosate in Alcohol-Dependent Individuals With Bipolar Disorder
Status:
COMPLETED
Status Verified Date:
2008-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether acamprosate Campral is safe and effective in treating alcohol dependence in individuals with bipolar disorder All subjects in the study must be currently stabilized on mood-stabilizing medication Half of the subjects will receive acamprosate in addition to their mood-stabilizing medication control subjects will be maintained on their mood-stabilizing medication alone Measures of alcohol use as well as mood stability will be obtained weekly throughout the active phase of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5K24DA000435-08 | NIH | None | httpsreporternihgovquickSearch5K24DA000435-08 |